02/25/2014
https://congress.gov...
"Today's legislative hearing focuses on three bills designed to improve the predictability and transparency in Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) regulation."
"H.R. 4299, which seeks to improve the transparency and consistency of DEA's scheduling of new FDA-approved drugs."
"This lack of predictability in the timing of DEA's scheduling decisions leads to unnecessary uncertainty in the drug development process."
"H.R. 4250, the Sunscreen Innovation Act, introduced by Representatives Whitfield and Dingell, seeks to expedite the FDA's approval process for active ingredients in sunscreens."